HDAC9 and neoplasm: The increased occurrence of low-grade tumors under Ent treatment (Fig. 7d) also agrees with the enhanced frequency of lipogenic fibroblasts by Ent (Fig. 8d–f), implying that the HDAC-regulated switch of stromal transcriptional programs is highly coordinated with tumor progression.